Late lung metastasis of endometrial cancer. Two rare cases of patients with late lung metastasis of primary endometrial cancer 14 and 17 years after initial treatment

R.F. Falkenstern-Ge, M. Wohlleber, M. Kimmich, S. Bode-Erdmann, G. Ott, M. Kohlhäufl (Gerlingen, Stuttgart, Germany)

Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology
Session: Instructive clinical aspects of thoracic oncology
Session type: Thematic Poster Session
Number: 1250
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R.F. Falkenstern-Ge, M. Wohlleber, M. Kimmich, S. Bode-Erdmann, G. Ott, M. Kohlhäufl (Gerlingen, Stuttgart, Germany). Late lung metastasis of endometrial cancer. Two rare cases of patients with late lung metastasis of primary endometrial cancer 14 and 17 years after initial treatment. Eur Respir J 2012; 40: Suppl. 56, 1250

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Early recurrence in complete resected non-small cell lung cancer patients
Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Year: 2017

Surgical treatment for lung metastases in patients with colorectal cancer
Source: Annual Congress 2011 - General thoracic surgery I
Year: 2011


Surgical treatment of locally recurrent lung cancer
Source: Annual Congress 2007 - Recurrence of lung cancer following resection with curative intent
Year: 2007


Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy
Source: Eur Respir J 2012; 39: 1437-1442
Year: 2012



A rare involvement in a male patient with non-small cell lung carcinoma: breast metastasis
Source: Eur Respir J 2005; 26: Suppl. 49, 538s
Year: 2005

Influence of histological subtypes of bronchioloalveolar carcinoma on prognosis and treatment
Source: Annual Congress 2006 - Prognostic factors in lung cancer
Year: 2006


Treatment of early (stage I/II) non-small cell lung cancer
Source: Annual Congress 2005 - PG2 - Lung cancer: non-small cell lung cancer treatment
Year: 2005


The risk of distant metastases and prognosis prediction in early stage squamous cell lung cancer (SqCLC) by means of 3 microRNAs expression assessment
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011


Age and stage at presentation in lung cancer
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005


Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease?
Source: Eur Respir J, 53 (3) 1801508; 10.1183/13993003.01508-2018
Year: 2019



Prevalence of silent brain metastasis (BM) in the initial staging of non-small cell lung carcinoma (NSCLC)
Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients
Year: 2011


Endobronchial intratumoral chemotherapy followed by surgery in early non-small-cell lung cancer with polypoid growth erroneously diagnosed as an advanced disease
Source: Eur Respir J 2006; 28: Suppl. 50, 610s
Year: 2006

Treatment choices in lung cancer patients with brain metastasis
Source: Eur Respir J 2001; 18: Suppl. 33, 378s
Year: 2001

Pulmonary re-biopsy in non–small-cell lung cancer (NSCLC) locally advanced or metastatic  with EGFR-T790M resistance.
Source: International Congress 2018 – Bronchoscopy and transthoracic ultrasound
Year: 2018

Neo-adjuvant chemotherapy: level of evidence in early stage and in marginally resectable disease
Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts
Year: 2005

How to treat a T1-T3N0 non-small cell lung cancer (NSCLC) with isolated brain metastasis
Source: International Congress 2015 – How to treat brain metastases
Year: 2015



Trends in drug costs and overall survival in patients diagnosed with metastatic non-small cell lung cancer (NSCLC)
Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness
Year: 2019


Surgical multimodality treatment for stage III non-small cell lung cancer (NSCLC)
Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer
Year: 2006


Management of brain metastases in patients with non-small cell lung cancer
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017


Combined resection of adjacent organ in NSCLC
Source: Annual Congress 2007 - Prognostic factors in lung cancer surgery
Year: 2007